老挝全球药房Laos Global Pharmacy
Carrying forward a five-thousand-year legacy, safeguarding modern health
莫洛替尼是全球首个获批用于伴中重度贫血的中高危骨髓纤维化成人患者的口服靶向药,属JAK1/2+ACVR1双重抑制剂。
所有称呼莫洛替尼、Momelotinib、Ojjaara、LuciMomel
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
Order on WhatsApp